Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
Alzheimer’s disease (AD) is an untreatable cause of dementia, and new therapeutic approaches are urgently needed. AD pathology is defined by extracellular amyloid plaques and intracellular neurofibrillary tangles. Research of the past decades has suggested that neuroinflammation plays a critical rol...
Main Authors: | Barbara E. Stopschinski, Rick A. Weideman, Danni McMahan, David A. Jacob, Bertis B. Little, Hsueh-Sheng Chiang, Nil Saez Calveras, Olaf Stuve |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-02-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864231156674 |
Similar Items
-
Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations
by: Olaf Stuve, et al.
Published: (2020-06-01) -
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
by: Nil Saez-Calveras, et al.
Published: (2022-10-01) -
The role of the complement system in Multiple Sclerosis: A review
by: Nil Saez-Calveras, et al.
Published: (2022-08-01) -
Cognitive Decline in Older People with Multiple Sclerosis—A Narrative Review of the Literature
by: Hsueh-Sheng Chiang, et al.
Published: (2022-06-01) -
Limb myorhythmia treated with chemodenervation: a case report
by: Nil Saez-Calveras, et al.
Published: (2023-03-01)